STARKAP Protocol: preliminary assessment of safety and tolerability of dostarlimab in combination antiretroviral therapy (cART)-refractory HIV associated Kaposi's Sarcoma.
Saved in:
| Title: | STARKAP Protocol: preliminary assessment of safety and tolerability of dostarlimab in combination antiretroviral therapy (cART)-refractory HIV associated Kaposi's Sarcoma. |
|---|---|
| Authors: | Fulgenzi, Claudia A. M.1 (AUTHOR) c.fulgenzi@imperial.ac.uk, Dalla Pria, Alessia2,3 (AUTHOR), Leone, Alberto Giovanni2,4 (AUTHOR), Martinez, Maria1 (AUTHOR), Del Peral, Elena Ferrer Martinez1 (AUTHOR), Flores, Maria Eleanor5 (AUTHOR), Bower, Mark2 (AUTHOR), Pinato, David J.1,6 (AUTHOR) |
| Source: | BMC Cancer. 7/1/2025, Vol. 25 Issue 1, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
